• Local contact QPPV (Bulgaria and Romania) and related Pharmacovigilance services to support Marketing Authorisation Holders (MAH) for achieving compliance with EU regulatory requirements (Regulation 1235/2010 and Directive 2010/84/EC) and local obligations to assign a local point of contact for pharmacovigilance for every registered product in the country.
  • Literature screening and follow-up assessment of relevant articles/scientific extracts. Medical review of cases in literature can help you identify important signals concerning the safety profile of your products.

    If you wish to report an adverse event, please use our "Contact Us" form. Thank you. We will revert to you as soon as possible.